Amarin Technologies is a duly organized Argentinean company settled in Buenos Aires, engaged in the development and formulation of topical and transdermal pharmaceutical products using its proprietary drug delivery technologies and know-how in order to offer both innovative formulations of well-established drugs or generic versions of marketed products.

With R&D, manufacturing, and clinical research capabilities, we own a 1200 sqm state-of-the-art manufacturing plant for transdermal systems involving all operations (mixing, coating, slitting, cutting, pouching and labelling), where our experienced team coordinates and manages the project planning and the product development programs. This plant allows us to have enough flexibility to manufacture from pilot GMP batches (i.e. to supply any clinical study needs) to commercial-scale batches.

We also possess modern formulation and analytical laboratories, which work following cGMP and GLP guidelines. R&D activities are rendered by a qualified team including Pharmacists, Chemists, Statisticians and university students.

In addition, we may also perform pre-clinical and BA/BE clinical studies in accordance with GLP and GCP guidelines, offering other companies study monitoring and statistical analysis services, as well as the organization of full clinical programs.